Winnergy Medical PCL
SET:WINMED
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Winnergy Medical PCL
Winnergy Medical PCL engages in distribution of medical equipment. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2021-05-11. The firm imports high technology medical and diagnostic products from around the world to help improve the lives of people in Thailand. The firm operates through two segments: Revenue from medical products and Revenue from other products. The firm's businesses include trading business and WINMED Laboratory Services. Its trading business includes women healthcare, blood banking, blood safety, cell therapy and other businesses. The firm imports products for cervical cancer detection and surgical gynecology from Hologic Company of the United States. The firm imports products related to blood donation from Haemonetics Company of the United States. The company distributes blood infection test products from Grifols of Spain. The firm imports stem cell and contamination analysis products with specimens from Germany's Miltenyi Biotec.
Winnergy Medical PCL engages in distribution of medical equipment. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2021-05-11. The firm imports high technology medical and diagnostic products from around the world to help improve the lives of people in Thailand. The firm operates through two segments: Revenue from medical products and Revenue from other products. The firm's businesses include trading business and WINMED Laboratory Services. Its trading business includes women healthcare, blood banking, blood safety, cell therapy and other businesses. The firm imports products for cervical cancer detection and surgical gynecology from Hologic Company of the United States. The firm imports products related to blood donation from Haemonetics Company of the United States. The company distributes blood infection test products from Grifols of Spain. The firm imports stem cell and contamination analysis products with specimens from Germany's Miltenyi Biotec.